Patent ID: 8779103
Filing Date: 2014-07-15
Classification: A61K,A61P,C07K

Abstract:
1. A drug fusion or conjugate comprising (a) an insulinotropic agent or an incretin drug selected from: (i) GLP-1, (ii) exendin-4, and (iii) PYY (Peptide YY), present as a fusion or a conjugate with (b) a dAb which binds serum albumin selected from: (i) the DOM 7h-14-10 domain antibody (dAb) (SEQ ID NO 26); (ii) the DOM 7h-11-15 dAb (SEQ ID NO 27); or (iii) the DOM 7h-14-10 R108C domain antibody (dAb) (SEQ ID NO 42).